Skip to main content
. 2015 Dec 1;25(12):1313–1321. doi: 10.1089/thy.2015.0098

Table 1.

Demographic and Tumor Characteristics at Baseline for NATCSS Participants

Demographic characteristics Cases, n (%) Tumor characteristics Cases, n (%)
Total 1174 Histology  
    Papillary 809 (69.2)
Sex   Follicular 65 (5.6)
Female 1055 (89.9) Medullary 45 (3.9)
Male 119 (10.1) Anaplastic 2 (0.2)
    Mixed 185 (15.8)
Race/ethnicity   Other 27 (2.3)
White 1126 (95.9) Don't know 36 (3.1)
Black 14 (1.2)    
Other 34 (2.9) Treatment  
  Mean (SD) Surgery 1129 (94.9)
Age at enrollment 48.0 (16.9) RAI 919 (77.2)
    Radiation 38 (3.2)
    Chemotherapy 8 (0.7)
Smoking      
Never 806 (68.7) Stage  
Ever 367 (31.3) 1 391 (33.9)
    2 184 (15.7)
Education   3 170 (14.5)
High school 385 (32.8) 4 95 (8.1)
College 364 (31.0) Don't know 331 (28.3)
More than college 420 (35.8)    
Missing   Time since diagnosis  
Marital status   0–1 year 289 (24.3)
Married 808 (68.8) 1–2 years 194 (16.3)
    2–3 years 120 (10.1)
Annual household income   3–4 years 97 (8.2)
<$35,000 106 (9.1) 4–5 years 95 (8.0)
$35,000–69,999 289 (24.8) 5–10 years 207 (17.4)
$70,000–119,999 330 (28.2) 10–20 years 123 (10.3)
≥$120,000 281 (24.1) 20+ years 65 (5.5)
Refused 160 (13.3)    
    Source of cases  
    Clinic 86 (7.2)
    Survivorship Groups (ThyCa, Bite Me Cancer) 943 (79.2)
    Social Media (Facebook, Twitter) 28 (2.4)
    Other (friends, etc.) 117 (11.2)

NATCSS, North American Thyroid Cancer Survivorship Study; RAI, radioactive iodine.